Alexander Rotenberg, Ph.D., M.D.
This page shows the publications co-authored by Alexander Rotenberg and Steven Schachter.
Damar U, Gersner R, Johnstone JT, Kapur K, Collins S, Schachter S, Rotenberg A. Alterations in the Timing of Huperzine A Cerebral Pharmacodynamics in the Acute Traumatic Brain Injury Setting. J Neurotrauma. 2018 01 15; 35(2):393-397.
Damar U, Gersner R, Johnstone JT, Schachter S, Rotenberg A. Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease. Med Hypotheses. 2017 Feb; 99:57-62.
Damar U, Gersner R, Johnstone JT, Schachter S, Rotenberg A. Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research. Expert Rev Neurother. 2016 06; 16(6):671-80.
Gersner R, Ekstein D, Dhamne SC, Schachter SC, Rotenberg A. Huperzine A prophylaxis against pentylenetetrazole-induced seizures in rats is associated with increased cortical inhibition. Epilepsy Res. 2015 Nov; 117:97-103.
Rotenberg A, Bae EH, Takeoka M, Tormos JM, Schachter SC, Pascual-Leone A. Repetitive transcranial magnetic stimulation in the treatment of epilepsia partialis continua. Epilepsy Behav. 2009 Jan; 14(1):253-7.
Leite J, Morales-Quezada L, Carvalho S, Thibaut A, Doruk D, Chen CF, Schachter SC, Rotenberg A, Fregni F. Surface EEG-Transcranial Direct Current Stimulation (tDCS) Closed-Loop System. Int J Neural Syst. 2017 Sep; 27(6):1750026.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.